<SEC-DOCUMENT>0001553350-18-000269.txt : 20180330
<SEC-HEADER>0001553350-18-000269.hdr.sgml : 20180330
<ACCEPTANCE-DATETIME>20180330134142
ACCESSION NUMBER:		0001553350-18-000269
CONFORMED SUBMISSION TYPE:	SC 13D/A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20180330
DATE AS OF CHANGE:		20180330

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Apollo Medical Holdings, Inc.
		CENTRAL INDEX KEY:			0001083446
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MANAGEMENT CONSULTING SERVICES [8742]
		IRS NUMBER:				870042699
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		SC 13D/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-84072
		FILM NUMBER:		18725643

	BUSINESS ADDRESS:	
		STREET 1:		700 NORTH BRAND BLVD.,
		STREET 2:		SUITE 1400
		CITY:			GLENDALE
		STATE:			CA
		ZIP:			91203
		BUSINESS PHONE:		818-839-5200

	MAIL ADDRESS:	
		STREET 1:		700 NORTH BRAND BLVD.,
		STREET 2:		SUITE 1400
		CITY:			GLENDALE
		STATE:			CA
		ZIP:			91203

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SICLONE INDUSTRIES INC
		DATE OF NAME CHANGE:	19990413

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp
		CENTRAL INDEX KEY:			0001725602
		IRS NUMBER:				954385217
		STATE OF INCORPORATION:			CA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13D/A

	BUSINESS ADDRESS:	
		STREET 1:		1668 S. GARFIELD AVE.
		STREET 2:		2ND FLOOR
		CITY:			ALHAMBRA
		STATE:			CA
		ZIP:			91801
		BUSINESS PHONE:		6262820288

	MAIL ADDRESS:	
		STREET 1:		1668 S. GARFIELD AVE.
		STREET 2:		2ND FLOOR
		CITY:			ALHAMBRA
		STATE:			CA
		ZIP:			91801
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13D/A
<SEQUENCE>1
<FILENAME>allied_sc13d.htm
<DESCRIPTION>SC 13D/A
<TEXT>
<!doctype html public "-//IETF//DTD HTML//EN">
<HTML>
<HEAD>
<TITLE>SC 13D</TITLE>
<META NAME="author" CONTENT="EDGAR FILING &nbsp;LLC">
<META NAME="date" CONTENT="10/26/2015">
</HEAD>
<BODY style="margin-top:0;font-family:Times New Roman; font-size:10pt; color:#000000">
<P style="margin:0px" align=center><BR></P>
<P style="margin-top:0px; margin-bottom:2.067px; padding-bottom:4px; border-bottom:4px solid #000000" align=right>&nbsp;</P>
<P style="margin:0px; padding-top:4px; border-top:1.333px solid #000000" align=right>&nbsp;</P>
<P style="margin:0px" align=center><B>UNITED STATES </B></P>
<P style="margin:0px" align=center><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P style="margin:0px" align=center><B>Washington, D.C. 20549</B></P>
<P style="line-height:8pt; margin:0px">&nbsp;</P>
<P style="margin:0px" align=center>&#151;&#151;&#151;&#151;&#151;&#151;&#151;</P>
<P style="margin:0px" align=center><B>SCHEDULE 13D</B></P>
<P style="margin:0px" align=center>&#151;&#151;&#151;&#151;&#151;&#151;&#151;</P>
<P style="line-height:8pt; margin:0px">&nbsp;</P>
<P style="margin:0px" align=center><B>Under the Securities Exchange Act of 1934</B></P>
<P style="margin:0px" align=center>(Amendment No. 1)<SUP>*</SUP></P>
<P style="line-height:8pt; margin:0px"><BR></P>
<P style="margin:0px; font-size:12pt" align=center><B>Apollo Medical Holdings, Inc.</B></P>
<P style="margin:0px; font-size:8pt" align=center><I>(Name of Issuer)</I></P>
<P style="line-height:8pt; margin:0px"><BR></P>
<P style="margin:0px" align=center><B>Common Stock</B></P>
<P style="margin:0px; font-size:8pt" align=center><I>(Title of Class of Securities)</I></P>
<P style="line-height:8pt; margin:0px">&nbsp;</P>
<P style="margin:0px" align=center><B>03763A207</B></P>
<P style="margin:0px; font-size:8pt" align=center><I>(CUSIP Number)</I></P>
<P style="line-height:8pt; margin:0px">&nbsp;</P>
<P style="margin:0px" align=center><B>Tin Kin Lee, Esq.</B></P>
<P style="margin:0px" align=center><B>1811 Fair Oaks Avenue</B></P>
<P style="margin:0px" align=center><B>South Pasadena, CA 91030</B></P>
<P style="margin:0px" align=center><B>(626) 229-9828</B></P>
<P style="margin:0px; font-size:8pt" align=center><I>(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)</I></P>
<P style="margin:0px" align=center><BR></P>
<P style="margin:0px" align=center><B>December 8, 2017</B></P>
<P style="margin:0px; font-size:8pt" align=center><I>(Date of Event which Requires Filing of this Statement)</I></P>
<P style="line-height:8pt; margin:0px"><BR></P>
<P style="margin:0px">If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of &#167;&#167;240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.&nbsp;<FONT style="font-family:Wingdings">&#168;</FONT></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><B>Note</B>: &nbsp;Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule&nbsp;13d-7 for other parties to whom copies are to be sent.</P>
<P style="line-height:8pt; margin:0px"><BR></P>
<P style="margin:0px"><BR></P>
<TABLE style="margin-top:0px; font-size:10pt" cellpadding=0 cellspacing=0 width=100%><TR height=0 style="font-size:0"><TD width=6.667 /><TD /></TR>
<TR><TD style="margin-top:0px" valign=top width=6.667><P style="margin:0px">*</P>
</TD><TD style="margin-top:0px" valign=top><P style="margin:0px">The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.</P>
</TD></TR>
</TABLE>
<P style="line-height:8pt; margin:0px; font-size:12pt">&nbsp;</P>
<P style="margin:0px">The information required on the remainder of this cover page shall not be deemed to be &quot;filed&quot; for the purpose of Section 18 of the Securities Exchange Act of 1934 (&quot;Act&quot;) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act.</P>
<P style="margin:0px"><BR></P>
<P style="margin:0px" align=center><BR></P>
<P style="margin-top:0px; margin-bottom:2.067px; padding-bottom:4px; border-bottom:1.333px solid #000000">&nbsp;&nbsp;</P>
<P style="margin:0px; padding-top:4px; border-top:4px solid #000000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P>
<P style="margin:0px"><BR>
<BR></P>
<HR style="margin-bottom:9.6px; padding-top:9.6px" noshade size=1.333>
<P style="margin:0px; page-break-before:always"><BR></P>
<TABLE style="margin-top:0px; font-size:10pt" cellpadding=0 cellspacing=0 width=100%><TR height=0 style="font-size:0"><TD width=177.6 /><TD /><TD width=177.533 /></TR>
<TR><TD style="margin-top:0px; background-color:#FFFFFF" width=177.6><P style="margin:0px">CUSIP No.&nbsp; <B>03763A207</B></P>
</TD><TD style="margin-top:0px; background-color:#FFFFFF"><P style="margin:0px" align=center><B>13D</B></P>
</TD><TD style="margin-top:0px; background-color:#FFFFFF" width=177.533><P style="margin:0px" align=right>Page&nbsp;2&nbsp;of&nbsp;5 Pages</P>
</TD></TR>
</TABLE>
<P style="margin:0px; font-size:12pt">&nbsp;</P>
<TABLE style="margin-top:0px; font-size:10pt" cellpadding=0 cellspacing=0 width=100%><TR height=0 style="font-size:0"><TD width=48.267 /><TD width=136.067 /><TD width=2.733 /><TD width=29.267 /><TD /></TR>
<TR><TD style="margin-top:0px; border:1px solid #000000" valign=top width=48.267><P style="margin:0px" align=center><B>1</B></P>
</TD><TD style="margin-top:0px; border-top:1px solid #000000; border-right:1px solid #000000; border-bottom:1px solid #000000" width=672.4 colspan=4><P style="margin:0px; padding-left:3.2px">NAME OF REPORTING PERSONS</P>
<P style="margin:0px"><BR></P>
<A NAME="_Hlk501103213"></A><P style="margin:0px; padding-left:3.2px; font-size:10.5pt"><B>Allied Physicians of California, A Professional Medical Corporation</B></P>
<P style="margin:0px; padding-left:3.2px">&nbsp;</P>
</TD></TR>
<TR><TD style="margin-top:0px; border-left:1px solid #000000; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=48.267><P style="margin:0px" align=center><B>2</B></P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" width=672.4 colspan=4><P style="margin:0px; padding-left:3.2px">CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP</P>
<P style="margin:0px; padding-left:3.2px">(a)&nbsp;&nbsp; <FONT style="font-family:Wingdings">&#168;</FONT></P>
<P style="margin:0px; padding-left:3.2px">(b)&nbsp;&nbsp; <FONT style="font-family:Wingdings">&#254;</FONT></P>
<P style="margin:0px; padding-left:3.2px">&nbsp;</P>
</TD></TR>
<TR><TD style="margin-top:0px; border-left:1px solid #000000; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=48.267><P style="margin:0px" align=center><B>3</B></P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=672.4 colspan=4><P style="margin:0px; padding-left:3.2px">SEC USE ONLY</P>
<P style="margin:0px; padding-left:3.2px">&nbsp;</P>
<P style="margin:0px; padding-left:3.2px">&nbsp;</P>
</TD></TR>
<TR><TD style="margin-top:0px; border-left:1px solid #000000; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=48.267><P style="margin:0px" align=center><B>4</B></P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=672.4 colspan=4><P style="margin:0px; padding-left:3.2px">SOURCE OF FUNDS</P>
<P style="margin:0px; padding-left:3.2px">&nbsp;</P>
<P style="margin:0px; padding-left:3.2px"><B>OO &#150; see item 4 below</B></P>
<P style="margin:0px; padding-left:3.2px">&nbsp;</P>
</TD></TR>
<TR><TD style="margin-top:0px; border-left:1px solid #000000; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=48.267><P style="margin:0px" align=center><B>5</B></P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=672.4 colspan=4><P style="margin:0px; padding-left:3.2px">CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS&nbsp;2(d) OR 2(e)</P>
<P style="margin:0px; padding-left:3.2px; font-family:Wingdings">&#168;</P>
<P style="margin:0px; padding-left:3.2px">&nbsp;</P>
</TD></TR>
<TR><TD style="margin-top:0px; border-left:1px solid #000000; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=48.267><P style="margin:0px" align=center><B>6</B></P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" width=672.4 colspan=4><P style="margin:0px; padding-left:3.2px">CITIZENSHIP OR PLACE OF ORGANIZATION</P>
<P style="margin:0px; padding-left:3.2px">&nbsp;</P>
<P style="margin:0px; padding-left:3.2px"><B>California</B></P>
<P style="margin:0px; padding-left:3.2px">&nbsp;</P>
</TD></TR>
<TR><TD style="margin-top:0px; border-left:1px solid #000000; border-bottom:1px solid #000000" width=48.267 rowspan=4><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px; border-bottom:1px solid #000000" width=136.067 rowspan=4><P style="margin:0px; padding-left:8.067px" align=center><B>NUMBER OF</B></P>
<P style="margin:0px; padding-left:8.067px" align=center><B>SHARES</B></P>
<P style="margin:0px; padding-left:8.067px" align=center><B>BENEFICIALLY</B></P>
<P style="margin:0px; padding-left:8.067px" align=center><B>OWNED BY EACH</B></P>
<P style="margin:0px; padding-left:8.067px" align=center><B>REPORTING</B></P>
<P style="margin:0px; padding-left:8.067px" align=center><B>PERSON WITH:</B></P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000" width=2.733><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=29.267><P style="margin:0px" align=center><B>7</B></P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top><P style="margin:0px; padding-left:3.2px">SOLE VOTING POWER</P>
<P style="margin:0px; padding-left:3.2px">&nbsp;</P>
<P style="margin:0px; padding-left:3.2px; font-size:10.5pt"><B>1,892,183</B></P>
<P style="margin:0px; padding-left:3.2px">&nbsp;</P>
</TD></TR>
<TR><TD style="margin-top:0px; border-right:1px solid #000000" width=2.733><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=29.267><P style="margin:0px" align=center><B>8</B></P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top><P style="margin:0px; padding-left:3.2px">SHARED VOTING POWER</P>
<P style="margin:0px"><BR></P>
<P style="margin:0px; padding-left:3.2px"><B>0</B></P>
<P style="margin:0px; padding-left:3.2px">&nbsp;</P>
</TD></TR>
<TR><TD style="margin-top:0px; border-right:1px solid #000000" width=2.733><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=29.267><P style="margin:0px" align=center><B>9</B></P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top><P style="margin:0px; padding-left:3.2px">SOLE DISPOSITIVE POWER</P>
<P style="margin:0px; padding-left:3.2px">&nbsp;</P>
<P style="margin:0px; padding-left:3.2px; font-size:10.5pt"><B>1,892,183</B></P>
<P style="margin:0px; padding-left:3.2px">&nbsp;</P>
</TD></TR>
<TR><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" width=2.733><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=29.267><P style="margin:0px" align=center><B>10</B></P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top><P style="margin:0px; padding-left:3.2px">SHARED DISPOSITIVE POWER</P>
<P style="margin:0px"><BR></P>
<P style="margin:0px; padding-left:3.2px"><B>0</B></P>
<P style="margin:0px; padding-left:3.2px">&nbsp;</P>
</TD></TR>
<TR><TD style="margin-top:0px; border-left:1px solid #000000; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=48.267><P style="margin:0px" align=center><B>11</B></P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=672.4 colspan=4><P style="margin:0px; padding-left:3.2px">AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON</P>
<P style="margin:0px"><BR></P>
<P style="margin:0px; padding-left:3.2px; font-size:10.5pt"><B>1,892,183</B></P>
<P style="margin:0px; padding-left:3.2px">&nbsp;</P>
</TD></TR>
<TR><TD style="margin-top:0px; border-left:1px solid #000000; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=48.267><P style="margin:0px" align=center><B>12</B></P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" width=672.4 colspan=4><P style="margin:0px; padding-left:3.2px">CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES</P>
<P style="margin:0px"><BR></P>
<P style="margin:0px; padding-left:3.2px; font-family:Wingdings">&#168;</P>
<P style="margin:0px; padding-left:3.2px">&nbsp;</P>
</TD></TR>
<TR><TD style="margin-top:0px; border-left:1px solid #000000; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=48.267><P style="margin:0px" align=center><B>13</B></P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" width=672.4 colspan=4><P style="margin:0px; padding-left:3.2px">PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)</P>
<P style="margin:0px"><BR></P>
<P style="margin:0px; padding-left:3.2px"><B>5.06%</B></P>
<P style="margin:0px; padding-left:3.2px">&nbsp;</P>
</TD></TR>
<TR><TD style="margin-top:0px; border-left:1px solid #000000; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=48.267><P style="margin:0px" align=center><B>14</B></P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=672.4 colspan=4><P style="margin:0px; padding-left:3.2px">TYPE OF REPORTING PERSON</P>
<P style="margin:0px"><BR></P>
<P style="margin:0px; padding-left:3.2px"><B>CO</B></P>
<P style="margin:0px; padding-left:3.2px">&nbsp;</P>
</TD></TR>
</TABLE>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR>
<BR></P>
<HR style="margin-bottom:9.6px; padding-top:9.6px" noshade size=1.333>
<P style="margin:0px; page-break-before:always"><BR></P>
<TABLE style="margin-top:0px; font-size:10pt" cellpadding=0 cellspacing=0 width=100%><TR height=0 style="font-size:0"><TD width=177.6 /><TD /><TD width=177.533 /></TR>
<TR><TD style="margin-top:0px; background-color:#FFFFFF" width=177.6><P style="margin:0px">CUSIP No.&nbsp; <B>03763A207</B></P>
</TD><TD style="margin-top:0px; background-color:#FFFFFF"><P style="margin:0px" align=center><B>13D</B></P>
</TD><TD style="margin-top:0px; background-color:#FFFFFF" width=177.533><P style="margin:0px" align=right>Page&nbsp;3&nbsp;of&nbsp;5 Pages</P>
</TD></TR>
</TABLE>
<P style="margin:0px; font-size:12pt">&nbsp;</P>
<P style="margin:0px"><BR></P>
<P style="margin:0px; padding-right:-16px">This Amendment No. 1 relates to the Schedule 13D originally filed on behalf of Allied Physicians of California, A Professional Medical Corporation (the &#147;Reporting Person&#148;) with the Securities and Exchange Commission on December 19, 2017. &nbsp;The text of Items 4 and 5 are hereby amended to correct the miscalculation of the percentage and number of shares of common stock of Apollo Medical Holdings, Inc (the &#147;Issuer&#148;), $.001 par value per share (&#147;Common Stock&#148;) deemed to be beneficially owned by the Reporting Person as of the date set forth on the cover page of this Schedule 13D/A.</P>
<P style="margin:0px"><BR></P>
<TABLE style="margin-top:0px; font-size:10pt" cellpadding=0 cellspacing=0 width=100%><TR height=0 style="font-size:0"><TD width=96.067 /><TD /></TR>
<TR><TD style="margin-top:0px" valign=top width=96.067><P style="margin:0px"><B>ITEM&nbsp;4.&nbsp;&nbsp;</B></P>
</TD><TD style="margin-top:0px" valign=top><P style="margin:0px"><B>PURPOSE OF TRANSACTION.</B></P>
</TD></TR>
</TABLE>
<P style="margin:0px"><BR></P>
<P style="margin:0px">On December 8, 2017, a reverse merger transaction between Network Medical Management, Inc., a California corporation (&#147;NMM&#148;) and the Issuer was consummated such that NMM became a wholly-owned subsidiary of the Issuer (the &#147;Merger&#148;). </P>
<P style="margin:0px"><BR></P>
<P style="margin:0px">Immediately prior to the closing of the Merger (the &#147;Closing&#148;), the Reporting Person was a shareholder of NMM. Pursuant to the Merger, the shares of NMM common stock previously held by Reporting Person were converted into (i) 1,682,109 shares of common stock of the Issuer, (ii) a warrant to purchase 52,262.84 shares of common stock of the Issuer exercisable at any time prior to December 8, 2022 at an exercise price of $11.00 per share, (iii) a warrant to purchase 55,337.13 shares of common stock of the Issuer exercisable at any time prior to December 8, 2022 at an exercise price of $10.00 per share, (iv) cash in lieu of fractional shares, and (v) the Reporting Person&#146;s pro rata portion, if any, of the holdback shares of common stock of the Issuer (such pro rata portion of the holdback shares would, without offset, initially be equal to 186,901.07 shares of Common Stock of the Issuer).</P>
<P style="margin:0px"><BR></P>
<P style="margin:0px">Immediately prior to the Closing, NMM made an in-kind distribution on a pro rata basis to its shareholders (including the Reporting Person) of the following warrants, which warrants were previously held by NMM: (i) 1,111,111 Series A warrants (of which the Reporting Person will receive 68,317.43 Series A warrants) to purchase common stock of the Issuer, exercisable at any time prior to October 14, 2020 at an exercise price of $9.00 per share, and (ii) 555,555 Series B warrants (of which the Reporting Person will receive 34,158.69 Series B warrants) to purchase common stock of the Issuer, exercisable at any time prior to March 30, 2021 at an exercise price of $10.00 per share.</P>
<P style="margin:0px"><BR></P>
<A NAME="_Hlk501359513"></A><P style="margin:0px">Pursuant to the terms of each of the warrants described above (the &#147;Warrants&#148;), no fractional shares shall be issuable upon exercise or conversion of the Warrants, and the number of shares to be issued shall be rounded down to the nearest whole share. &nbsp;If a fractional share interest arises upon any exercise or conversion of the Warrants, the Issuer shall eliminate such fractional share interest by paying the holder of the Warrants cash in the amount computed by multiplying the fractional share interest by the fair market value of a full share, as determined in accordance with the terms of the Warrants. &nbsp;As such, the number and percentage of shares of Common Stock beneficially owned by the Reporting Person excludes all fractional shares of Common Stock issuable upon the exercise or conversion of the Warrants.</P>
<P style="margin:0px"><BR></P>
<P style="margin:0px">The Reporting Person does not have any present plan or proposal which would relate to or result in any of the matters set forth in subparagraphs (a)&#173;(j) of Item 4 of Schedule 13D except as set forth herein or such as would occur upon completion of any of the actions discussed above. </P>
<P style="margin:0px"><BR>
<BR></P>
<HR style="margin-bottom:9.6px; padding-top:9.6px" noshade size=1.333>
<P style="margin:0px; page-break-before:always"><BR></P>
<TABLE style="margin-top:0px; font-size:10pt" cellpadding=0 cellspacing=0 width=100%><TR height=0 style="font-size:0"><TD width=177.6 /><TD /><TD width=177.533 /></TR>
<TR><TD style="margin-top:0px; background-color:#FFFFFF" width=177.6><P style="margin:0px">CUSIP No.&nbsp; <B>03763A207</B></P>
</TD><TD style="margin-top:0px; background-color:#FFFFFF"><P style="margin:0px" align=center><B>13D</B></P>
</TD><TD style="margin-top:0px; background-color:#FFFFFF" width=177.533><P style="margin:0px" align=right>Page&nbsp;4&nbsp;of&nbsp;5 Pages</P>
</TD></TR>
</TABLE>
<P style="margin:0px"><BR></P>
<TABLE style="margin-top:0px; font-size:10pt" cellpadding=0 cellspacing=0 width=100%><TR height=0 style="font-size:0"><TD width=96.067 /><TD /></TR>
<TR><TD style="margin-top:0px" valign=top width=96.067><P style="margin:0px"><B>ITEM&nbsp;5.&nbsp;&nbsp;</B></P>
</TD><TD style="margin-top:0px" valign=top><P style="margin:0px"><B>INTEREST IN SECURITIES OF THE ISSUER.</B></P>
</TD></TR>
</TABLE>
<P style="margin:0px"><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; width:48px; float:left">(a)</P>
<P style="margin:0px; text-indent:-2px">The Reporting Person&#146;s beneficial ownership and percentage of Common Stock as of the date set forth on the cover page of this Schedule 13D/A is reflected on said cover page.</P>
<P style="margin:0px; clear:left"><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; width:48px; float:left">(b)</P>
<P style="margin:0px; text-indent:-2px">The Reporting Person has the sole power to vote or to direct the voting of 1,892,183 shares of Common Stock, and has the sole power to dispose or to direct the disposition of such number of shares.</P>
<P style="margin:0px; clear:left"><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; width:48px; float:left">(c)</P>
<P style="margin:0px; text-indent:-2px">See Item 4 of this Schedule 13D/A.</P>
<P style="margin:0px; clear:left"><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; width:48px; float:left">(d)</P>
<P style="margin:0px; text-indent:-2px">Not applicable.</P>
<P style="margin:0px; clear:left"><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; width:48px; float:left">(e)</P>
<P style="margin:0px; text-indent:-2px">Not applicable.</P>
<P style="margin:0px; font-size:12pt; clear:left">&nbsp;</P>
<P style="margin:0px"><BR></P>
<P style="margin:0px">&nbsp;</P>
<P style="margin:0px" align=right>&nbsp;&nbsp;</P>
<P style="margin:0px">&nbsp;</P>
<P style="margin:0px"><BR>
<BR></P>
<HR style="margin-bottom:9.6px; padding-top:9.6px" noshade size=1.333>
<P style="margin:0px; page-break-before:always"><BR></P>
<TABLE style="margin-top:0px; font-size:10pt" cellpadding=0 cellspacing=0 width=100%><TR height=0 style="font-size:0"><TD width=177.6 /><TD /><TD width=177.533 /></TR>
<TR><TD style="margin-top:0px; background-color:#FFFFFF" width=177.6><P style="margin:0px">CUSIP No.&nbsp; <B>03763A207</B></P>
</TD><TD style="margin-top:0px; background-color:#FFFFFF"><P style="margin:0px" align=center><B>13D</B></P>
</TD><TD style="margin-top:0px; background-color:#FFFFFF" width=177.533><P style="margin:0px" align=right>Page&nbsp;5&nbsp;of&nbsp;5 Pages</P>
</TD></TR>
</TABLE>
<P style="margin:0px; font-size:12pt">&nbsp;</P>
<P style="margin:0px"><BR></P>
<P style="margin:0px; font-size:12pt" align=center><B>SIGNATURE</B></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px">After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.</P>
<P style="margin:0px"><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; width:48px; float:left">Dated:</P>
<P style="margin:0px; text-indent:-2px">March 29, 2018</P>
<P style="margin:0px; clear:left"><BR></P>
<TABLE style="margin-top:0px; font-size:10pt" cellpadding=0 cellspacing=0 width=100%><TR height=0 style="font-size:0"><TD /><TD width=29.067 /><TD width=250.267 /><TD width=85.4 /></TR>
<TR><TD style="margin-top:0px; background-color:#FFFFFF" valign=top><P style="margin:0px">&nbsp;</P>
</TD><TD style="margin-top:0px; background-color:#FFFFFF" valign=top width=279.333 colspan=2><P style="margin:0px"><B>Allied Physicians of California, <BR>
A Professional Medical Corporation</B></P>
</TD><TD style="margin-top:0px; background-color:#FFFFFF" valign=top width=85.4><P style="margin:0px">&nbsp;</P>
</TD></TR>
<TR><TD style="margin-top:0px; background-color:#FFFFFF" valign=top><P style="margin:0px">&nbsp;</P>
</TD><TD style="margin-top:0px; background-color:#FFFFFF" valign=top width=29.067><P style="margin:0px">&nbsp;</P>
</TD><TD style="margin-top:0px; background-color:#FFFFFF" valign=top width=250.267><P style="margin:0px">&nbsp;</P>
</TD><TD style="margin-top:0px; background-color:#FFFFFF" valign=top width=85.4><P style="margin:0px">&nbsp;</P>
</TD></TR>
<TR><TD style="margin-top:0px; background-color:#FFFFFF; border-bottom:2.667px solid #FFFFFF" valign=top><P style="margin:0px">&nbsp;</P>
</TD><TD style="margin-top:0px; background-color:#FFFFFF; border-bottom:2.667px solid #FFFFFF" valign=top width=29.067><P style="margin:0px">By: </P>
</TD><TD style="margin-top:0px; background-color:#FFFFFF; border-bottom:1px solid #000000" valign=top width=250.267><P style="margin:0px">&nbsp;/s/ Thomas Lam, M.D.</P>
</TD><TD style="margin-top:0px; background-color:#FFFFFF; border-bottom:2.667px solid #FFFFFF" valign=top width=85.4><P style="margin:0px">&nbsp;</P>
</TD></TR>
<TR><TD style="margin-top:0px; background-color:#FFFFFF" valign=top><P style="margin:0px">&nbsp;</P>
</TD><TD style="margin-top:0px; background-color:#FFFFFF" valign=top width=29.067><P style="margin:0px">&nbsp;</P>
</TD><TD style="margin-top:0px; background-color:#FFFFFF" valign=bottom width=250.267><P style="margin:0px">Name: Thomas Lam, M.D.</P>
</TD><TD style="margin-top:0px; background-color:#FFFFFF" valign=top width=85.4><P style="margin:0px">&nbsp;</P>
</TD></TR>
<TR><TD style="margin-top:0px; background-color:#FFFFFF" valign=top><P style="margin:0px">&nbsp;</P>
</TD><TD style="margin-top:0px; background-color:#FFFFFF" valign=top width=29.067><P style="margin:0px">&nbsp;</P>
</TD><TD style="margin-top:0px; background-color:#FFFFFF" valign=top width=250.267><P style="margin:0px; padding-left:36px; text-indent:-36px">Title: Chief Executive Officer</P>
</TD><TD style="margin-top:0px; background-color:#FFFFFF" valign=top width=85.4><P style="margin:0px">&nbsp;</P>
</TD></TR>
<TR><TD style="margin-top:0px; background-color:#FFFFFF" valign=top><P style="margin:0px">&nbsp;</P>
</TD><TD style="margin-top:0px; background-color:#FFFFFF" valign=top width=29.067><P style="margin:0px">&nbsp;</P>
</TD><TD style="margin-top:0px; background-color:#FFFFFF" valign=top width=250.267><P style="margin:0px">&nbsp;</P>
</TD><TD style="margin-top:0px; background-color:#FFFFFF" valign=top width=85.4><P style="margin:0px">&nbsp;</P>
</TD></TR>
</TABLE>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR>
<BR></P>
</BODY>
<!-- EDGAR Validation Code: A6D806FA -->
</HTML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
